Biotech · Private company
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Track this companyFree. Adds InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Sham InjectionPhase 3 · Nutritional and Metabolic DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- stannsoporfinPhase 3 · Nutritional and Metabolic DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- PhototherapyPhase 2 · Jaundice, NeonatalClinicalTrials.gov · fetched Nov 12, 2026
- PhotoTherapy (as needed)Phase 2 · Hyperbilirubinemia, NeonatalClinicalTrials.gov · fetched Nov 12, 2026
- StannsoporfinPhase 2 · Hyperbilirubinemia, NeonatalClinicalTrials.gov · fetched Nov 12, 2026
- StannsoporfinPhase 2 · Jaundice, NeonatalClinicalTrials.gov · fetched Nov 12, 2026
- Stanate (TM) [stannsoporfin, tin-mesoporphyrin]Neonatal JaundiceClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Stannsoporfin With Light Therapy for Newborn Babies With JaundicePHASE2 · COMPLETED · started Oct 16, 2013ClinicalTrials.gov NCT01887327 · fetched Nov 12, 2026
- A Safety and Efficacy Trial of Stannsoporfin in Neonates With HyperbilirubinemiaPHASE2 · TERMINATED · started Aug 1, 2008ClinicalTrials.gov NCT00850993 · fetched Nov 12, 2026
- Efficacy and Safety of Stannsoporfin in NeonatesPHASE3 · COMPLETED · started May 1, 2002ClinicalTrials.gov NCT02685137 · fetched Nov 12, 2026
- Compassionate Use of Stanate (TM) [Stannsoporfin]NO_LONGER_AVAILABLEClinicalTrials.gov NCT00076960 · fetched Nov 12, 2026